Grace, Syntax I и Syntax II скор као предиктори једногодишњег МАЦЕ исхода код пацијената лечених перкутаном коронарном интервенцијом

  • Aleksandar Davidović University of Belgrade, Faculty of Dental Medicine, Belgrade, Serbia
  • Dane Cvijanović Clinical Hospital Center Zvezdara, Department of Interventional Cardiology, Belgrade, Serbia
  • Jelica Davidović Clinical Hospital Center Zvezdara, Department of Interventional Cardiology, Belgrade, Serbia
  • Snežana Lazić University of Priština/Kosovska Mitrovica, Faculty of Medicine, Internal Medicine Clinic, Kosovska Mitrovica, Serbia
  • Bratislav Lazić University of Priština/Kosovska Mitrovica, Faculty of Medicine, Surgical Clinic, Kosovska Mitrovica, Serbia
  • Luka Čučić Clinical Hospital Center Zvezdara, Department of Interventional Cardiology, Belgrade, Serbia
  • Marija Milić University of Priština/Kosovska Mitrovica, Faculty of Medicine, Institute of Epidemiology, Kosovska Mitrovica, Serbia
  • Nataša Marković Nikolić Clinical Hospital Center Zvezdara, Department of Interventional Cardiology, Belgrade, Serbia
Ključne reči: акутни инфаркт миокарда, перкутана коронарна интервенција

Sažetak


Проспективна, опсервациона, кохортна студија је омогућила праћење клиничких параметара GRACE, SYNTAX  I и II  скора. Истраживањем је обухваћено је 400 болесника са дијагнозом AIM, лечених и праћених годину дана

Уочен је статистички значајан висок степен корелације између GRACE скора са SYNTAX  I и SYNTAX  II скором (rho > 0,5; p=0,001). Регресионом анализом GRACE скора запажено је да је виши GRACE скор значајан предиктор виших вредности SYNTAX  I и II  скора у целом узорку болесника са дијагнозом AIM лечених перкутаном коронарном интервенцијом тј. код болесника са СТЕМИ инфарктом миокарда, док то није запажено у групи болесника са НСТЕМИ. Вредност GRACE скора је идентификована као оптимална вредност за предвиђање MACE исхода са сензитивношћу од 74,5% и специфичношћу од 61,6%. Скор SYNTAX  I са прецизношћу од 89,1% је предвидео (AUC = 0,89; 95% IP = 0,84–0,93; p = 0,001) појаву MACEисхода код наших болесника. Вредност SYNTAX  I скора је идентификована као оптимална вредност за предвиђање MACE исхода са  сензитивношћу од 86,3% и специфичношћу од 79,4%. SYNTAX  II скор је објаснио појаву MACE исхода код 90,5% наших испитаника (AUC = 0,9; 95% IP = 0, 89; p = 0,001). Вредност SYNTAX  II је идентификована као оптимална вредност за предвиђање MACE исхода са сензитивношћу од 88,2% и специфицношћу од 76,8%.

Закључак GRACE, SYNTAX  I и II  скор код пацијената са AIM који су подвргнути PCI  су независни и снажни предиктори MACE исхода интрахоспитално али и  током периода од годину дана.

Reference

Institute of Public Health of Serbia “Dr. Milan Jovanovic Batut”. Incidence and mortality of Acute Coronary Syndrome in Serbia. 2017. Available from: http://www.batut.org.rs/dow

nload/publikacije/2017Akutni%20koronarni%20sindrom.pdf

Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64(24): e139‒e228.

Bailleul C, Aissaoui N, Cayla G, Dillinger JG, Jouve B, Schiele F, et al. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry. Arch Cardiovasc Dis 2018; 111(2): 101‒8.

Institute of Public Health of Serbia "Dr. Milan Jovanović Batut". Incidence and mortality from acute coronary syndrome in Serbia. Registry for acute coronary syndrome in Serbia. Belgrade: Institute of Public Health of Serbia "Dr. Milan Jovanović Batut"; 2011. Report No. 6: 1‒107.

Writing Group Members. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133(4): e38‒360.

DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980: 303: 897‒ 902.

Song YB, Hahn JY, Kim JH, Lee SY, Choi SH, Choi JH, et al. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol 2010; 106(10): 1397‒403.

Magliano CADS, Monteiro AL, Tura BR, Oliveira CSR, Rebelo ARO, Pereira CCA. Patient and physician preferences for attributes of coronary revascularization. Patient Prefer Adherence 2018; 12: 757‒64.

Santos IS, Goulart AC, Brandão RM, Santos RC, Bittencourt MS, Sitnik D, et al. One-year Mortality after an Acute Coronary Event and its Clinical Predictors: The ERICO Study. Arq Bras Cardiol 2015; 105(1): 53‒64.

Garcia E, Moreno R, Abeytua M, Marco J. Mechanical reperfusion in AMI searching for optimal myocardial perfusion. In: Marco J, editor. The Paris Course on Revascularization. Paris: EuroPCR; 2003. p. 219‒41.

Gilutz H, Shindel S, Shoham-Vardi I. Adherence to NSTEMI Guidelines in the Emergency Department: Regression to Reality. Crit Pathw Cardiol 2019; 18(1): 40‒6.

Yan F, Liu H, Jiang W. Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST-elevation myocardial infarction: A systematic review and meta-analysis protocol. Medicine (Baltimore) 2019; 98(26): e16226.

Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121(24): 2645‒53.

de Araújo Gonçalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005; 26(9): 865‒72.

Gale CP, Manda SO, Weston CF, Birkhead JS, Batin PD, Hall AS. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart 2009; 95(3): 221‒7.

Huang W, FitzGerald G, Goldberg RJ, Gore J, McManus RH, Awad H, et al. TRACE-CORE Investigators. Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death After Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort. Am J Cardiol 2016; 118(8): 1105‒10.

Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1(2): 219‒27.

Kul S, Akgul O, Uyarel H, Ergelen M, Kucukdagli OT, Tasal A, et al. High SYNTAX score predicts worse in-hospital clinical outcomes in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2012; 23(8): 542‒8.

Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381(9867): 639‒50.

Yang H, Zhang L, Xu CH. Use of the SYNTAX Score II to predict mortality in interventional cardiology: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98(2): e14043.

Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007; 153(1): 29‒35.

Aktürk E, Aşkın L, Taşolar H, Türkmen S, Kaya H. Comparison of the Predictive Roles of Risk Scores of In-Hospital Major Adverse Cardiovascular Events in Patients with Non-ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Med Princ Pract 2018; 27(5): 459‒65.

Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291(22): 2727‒33.

Rahmani R, Majidi B, Ariannejad H, Shafiee A. The Value of the GRACE Score for Predicting the SYNTAX Score in Patients with Unstable Angina/Non-ST Elevation Myocardial Infarction. Cardiovasc Revasc Med 2020; 21(4): 514‒7.

Objavljeno
2022/11/01
Rubrika
Originalni članak